Case number 1:20-cv-00893
Astellas US LLC et al v. Hospira, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 1, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the entry of the Final Judgment in Lead Case No. 18-1675-CFC. (nmf) |
| Aug 20, 2021 | 12 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Greg J. Winter as co-counsel. Reason for request: Left Firm. (Gattuso, Dominick) |
| Jul 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gregory J. Winter for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jul 17, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Claire A. Fundakowski for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 1:20-cv-00893-CFC) Stipulation to Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 20-893-CFC and C.A. No. 18-1675-CFC are consolidated forall purposes;All filings shall be made in C.A. No. 18-1675-CFC. Ordered by Judge Colm F. Connolly on 7/15/2020. Associated Cases: 1:20-cv-00893-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Jul 15, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01675-CFC-CJB. ALL FILINGS SHALL BE MADE IN C.A. NO. 18-1675-CFC. (fms) |
| Jul 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jul 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski, and Gregory J. Winter filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 7/13/2020. (fms) |
| Jul 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jovial Wong for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 10, 2020 | 11 | Stipulation (6) Docket Text: STIPULATION Stipulation and Proposed Order to Consolidate Action by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 8, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) |
| Jul 7, 2020 | 10 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira, Inc.s Core Technical Documents Bates labeled HOS00000001 - HOS00004839 [HIGHLY CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Jul 6, 2020 | 7 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, Hospira, Inc.'s Answer, Defenses and Counterclaims, COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Hospira, Inc..(Gattuso, Dominick) |
| Jul 6, 2020 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Hospira, Inc. filed by Hospira, Inc.. (Gattuso, Dominick) |
| Jul 6, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski, and Gregory J. Winter - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Jul 1, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (mal) |
| Jun 30, 2020 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Hospira, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3028894.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(mal) |
| Jun 30, 2020 | 1 | Exhibit A (22) |
| Jun 30, 2020 | 1 | Exhibit B (22) |
| Jun 30, 2020 | 1 | Exhibit C (20) |
| Jun 30, 2020 | 1 | Exhibit D (18) |
| Jun 30, 2020 | 1 | Civil Cover Sheet (1) |
| Jun 30, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Jun 30, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 16, 2020. Date of Expiration of Patent: February 2, 2027.Thirty Month Stay Deadline: 12/16/2022. (mal) |
| Jun 30, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (mal) |
| Jun 30, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC. Astellas Pharma Inc. is the sole shareholder of Astellas US Holding, Inc. filed by Astellas Pharma US, Inc., Astellas US LLC. (mal) |
| Jun 30, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (mal) |
